New VCS Patient Portal: InteliChart
Launching the week of January 26
January 28, 2026: If you received an email invitation from noreply@nextgen.com to register for the PxP patient portal, please disregard it. This message was sent in error. You will receive a new invitation for our updated patient portal within the week from no-reply@patientportal.net.
Virginia Cardiovascular Specialists is launching a new patient portal, InteliChart, to make it easier for patients to communicate with their care team and manage heart care online.
Why VCS Is Introducing a New Patient Portal
Our new patient portal provides:
- A more intuitive, user-friendly experience
- Secure messaging reduces phone tag
- Easier prescription refill requests
This update helps improve communication, reduce phone wait times, and support more efficient care.
What Patients Need to Know
- Monday, January 26: The new patient portal, InteliChart, goes live! If you need access to the old portal after January 26, click here. It will be read-only until June 2026.
- Patients will need to register for the new portal, even if they used our previous portal.
- Patients with a scheduled appointment with VCS will receive an email invitation from no-reply@patientportal.net to register.
- Medical records are not lost during the transition period from January 20 to 25.
Frequently Asked Questions About the New Patient Portal
What will my username be?
Your username will be the email address we have on file for you.
Will my old messages transfer to InteliChart?
Your old messages will remain part of your medical record, but will not appear in the new portal.
What if I can’t log in or didn’t receive an email invitation?
Please call your VCS office to ask a team member to resend your registration link.
Will I have access the old patient portal?
You can access the old portal here. Please note that from January 20 until June 2026, the old portal will be READ-ONLY. Your old messages will remain part of your medical record in the new portal, but patients will not be able to see them.